Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient trial designs to reduce placebo requirements.

K R Krishnan1

  • 1Department of Psychiatry, Duke University Medical Center, Box 3018, Durham, NC 27710, USA.

Biological Psychiatry
|April 22, 2000
PubMed
Summary

New clinical trial designs may reduce placebo exposure in antidepressant studies. However, these complex designs require further evaluation before widespread adoption for assessing treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studies on emulsion-type buffalo meat sausages incorporating skeletal and offal meat with different levels of pork fat.

Meat science·2011
Same author

Long-Term Use of Benzodiazepines: Implications and guidelines.

Canadian family physician Medecin de famille canadien·2011
Same author

Multiple rare SAPAP3 missense variants in trichotillomania and OCD.

Molecular psychiatry·2008
Same author

Psychiatric disease in the genomic era: rational approach.

Molecular psychiatry·2005
Same author

Delirium: diagnosis, neuropathogenesis, and treatment.

Journal of psychiatric practice·2005
Same author

Quality of life in patients with spinal cord injury--basic issues, assessment, and recommendations.

Restorative neurology and neuroscience·2002

Area of Science:

  • Clinical research methodology
  • Psychopharmacology
  • Drug efficacy trials

Background:

  • Assessing antidepressant efficacy often involves placebo-controlled trials.
  • A significant number of participants may receive ineffective placebo treatment.
  • Ethical considerations and participant burden necessitate exploring alternatives.

Purpose of the Study:

  • To discuss potential modifications in clinical trial designs.
  • To explore methods for minimizing subject exposure to ineffective treatments, specifically placebo.
  • To evaluate the feasibility and utility of novel trial paradigms.

Main Methods:

  • Review of existing literature on adaptive and innovative clinical trial designs.
  • Conceptual discussion of design modifications aimed at reducing placebo arms.
  • Analysis of the complexity and implementation challenges of these designs.

Main Results:

  • Several complex trial designs could potentially reduce placebo exposure.
  • These advanced designs have not been sufficiently implemented or validated.
  • Limited data exists on the practical utility and reliability of these novel approaches.

Conclusions:

  • Further research and pilot studies are essential before adopting these complex designs.
  • The utility of these designs for assessing antidepressant efficacy remains to be definitively proven.
  • Careful consideration and validation are required prior to implementing these paradigms as a primary assessment method.

Related Experiment Videos